PAX: Paxman AB (publ) - Summary | Jitta

Paxman AB (publ)

SWE:PAX

Price
kr48.60
Loss Chance
49.2%
4.26JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
29 / 105
266 / 618
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (54)
Recent Business Performance (22)
Financial Strength (64)
Return to Shareholders (8)
Competitive Advantage (53)
Jitta Signs
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 133.97% in the last year
Key Stats
Jitta Score
Jitta Line
4.26
> 1,000%
2.89
158.61%
Health Care Equipment
3.67
100.00%
4.58
22.78%
4.08
45.86%
COMPANY DESCRIPTION
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.